Informations techniques
Exploitant
LUPIN EUROPE GmbH
Présentation
NAMUSCLA 167 mg, gélule
B/30 (CIP : 34009 301 721 2 4)
B/50 (CIP : 34009 301 721 3 1)
B/100 (CIP : 34009 301 721 4 8)
B/200 (CIP : 34009 550 625 8 5)
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
ZNjM9SREAX2JqFNZ